Sedana Medical AB (publ) (FRA:7D2A)

Market Cap	94.67M -31.3%
Revenue (ttm)	17.87M +13.5%
Net Income	-3.68M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.9640
Previous Close	0.9610
Day's Range	0.9640 - 0.9640
52-Week Range	0.5790 - 1.8040
Beta	n/a
RSI	56.48
Earnings Date	Feb 12, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Employees: 117
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7D2A

Financial Performance

In 2024, Sedana Medical AB's revenue was 178.75 million, an increase of 16.17% compared to the previous year's 153.87 million. Losses were -10.67 million, -82.09% less than in 2023.

Financial numbers in SEK